Hannah Harrison - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Hannah Harrison

Showing results (51-60 of 53) with videos related to

Pageof 6

Sort By:

You have reached the last page of results.This site can display upto 53 results.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 7, 2013

Targeting treatment-resistant breast cancer stem cells with FKBPL and its peptide derivative, AD-01, via the CD44 pathwayLana McClements, Anita Yakkundi, Angelos Papaspyropoulos, et al.

BMJ Oncology|June 16, 2025

A systematic review comparing surveillance recommendations for the detection of recurrence following surgery across 16 common cancer typesHannah Harrison, Bhumi K Shah, Faris Khan, et al.

Nature|November 5, 2025

Anti-progestin therapy targets hallmarks of breast cancer riskBruno M Simões, Robert Pedley, Curtis W McCloskey, et al.

Pageof 6

Search research articles

Showing results (51-60 of 53) with videos related to

Sort By:

Pageof 6

You have reached the last page of results.This site can display upto 53 results.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 7, 2013

Targeting treatment-resistant breast cancer stem cells with FKBPL and its peptide derivative, AD-01, via the CD44 pathwayLana McClements, Anita Yakkundi, Angelos Papaspyropoulos, et al.

BMJ Oncology|June 16, 2025

A systematic review comparing surveillance recommendations for the detection of recurrence following surgery across 16 common cancer typesHannah Harrison, Bhumi K Shah, Faris Khan, et al.

Nature|November 5, 2025

Anti-progestin therapy targets hallmarks of breast cancer riskBruno M Simões, Robert Pedley, Curtis W McCloskey, et al.

Pageof 6